271 related articles for article (PubMed ID: 16855011)
1. Phase I/II trial of hyperfractionated accelerated chemoradiotherapy for unresectable advanced pancreatic cancer.
Tsujie M; Nakamori S; Tanaka E; Nagano H; Umeshita K; Dono K; Sakon M; Inoue T; Inoue T; Monden M
Jpn J Clin Oncol; 2006 Aug; 36(8):504-10. PubMed ID: 16855011
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).
Ishida K; Ando N; Yamamoto S; Ide H; Shinoda M
Jpn J Clin Oncol; 2004 Oct; 34(10):615-9. PubMed ID: 15591460
[TBL] [Abstract][Full Text] [Related]
3. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial.
Budach V; Stuschke M; Budach W; Baumann M; Geismar D; Grabenbauer G; Lammert I; Jahnke K; Stueben G; Herrmann T; Bamberg M; Wust P; Hinkelbein W; Wernecke KD
J Clin Oncol; 2005 Feb; 23(6):1125-35. PubMed ID: 15718308
[TBL] [Abstract][Full Text] [Related]
4. Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin.
Kornek GV; Schratter-Sehn A; Marczell A; Depisch D; Karner J; Krauss G; Haider K; Kwasny W; Locker G; Scheithauer W
Br J Cancer; 2000 Jan; 82(1):98-103. PubMed ID: 10638974
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial.
Chen GY; Jiang GL; Wang LJ; Qian H; Fu XL; Yang H; Wu KL; Zhao S
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):70-5. PubMed ID: 15629596
[TBL] [Abstract][Full Text] [Related]
6. Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study.
Al-Sukhun S; Zalupski MM; Ben-Josef E; Vaitkevicius VK; Philip PA; Soulen R; Weaver D; Adsay V; Heilbrun LK; Levin K; Forman JD; Shields AF
Am J Clin Oncol; 2003 Dec; 26(6):543-9. PubMed ID: 14663369
[TBL] [Abstract][Full Text] [Related]
7. [5-FU, folinic acid and cisplatin (LV5FU2-P) for unresectable pancreatic cancer].
Taïeb J; Lecomte T; Ezenfis J; Artru P; Mitry E; Boige V; Clavero-Fabri MC; Vaillant JN; Rougier P; Ducreux M
Gastroenterol Clin Biol; 2002; 26(6-7):605-9. PubMed ID: 12193860
[TBL] [Abstract][Full Text] [Related]
8. A phase I/II study of nedaplatin and 5-fluorouracil with concurrent radiotherapy in patients with esophageal cancer.
Sato Y; Takayama T; Sagawa T; Okamoto T; Miyanishi K; Sato T; Araki H; Iyama S; Abe S; Murase K; Takimoto R; Nagakura H; Hareyama M; Kato J; Niitsu Y
Cancer Chemother Pharmacol; 2006 Nov; 58(5):570-6. PubMed ID: 16463059
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of hyperfractionated accelerated split-course radiochemotherapy with 5-FU and Cis-DDP in advanced head and neck cancer: results and toxicity.
Ernst-Stecken A; Grabenbauer G; Iro H; Plasswilm L; Sauer R
Strahlenther Onkol; 2004 Dec; 180(12):805-10. PubMed ID: 15592701
[TBL] [Abstract][Full Text] [Related]
10. Intra-arterial infusion chemotherapy with 5-fluorouracil and cisplatin in advanced pancreatic cancer: a feasibility study.
Sasada T; Denno R; Tanaka T; Kanai M; Mizukami Y; Kohno S; Takabayashi A
Am J Clin Oncol; 2008 Feb; 31(1):71-8. PubMed ID: 18376231
[TBL] [Abstract][Full Text] [Related]
11. Toxicities and effects of involved-field irradiation with concurrent cisplatin for unresectable carcinoma of the pancreas.
Kawakami H; Uno T; Isobe K; Ueno N; Aruga T; Sudo K; Yamaguchi T; Saisho H; Kawata T; Ito H
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1357-62. PubMed ID: 16029793
[TBL] [Abstract][Full Text] [Related]
12. Clinical experience with chronomodulated infusional 5-fluorouracil chemoradiotherapy for pancreatic adenocarcinoma.
Keene KS; Rich TA; Penberthy DR; Shepard RC; Adams R; Jones RS
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):97-103. PubMed ID: 15850908
[TBL] [Abstract][Full Text] [Related]
13. Intraoperative and conformal external-beam radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic carcinoma.
Furuse J; Kinoshita T; Kawashima M; Ishii H; Nagase M; Konishi M; Nakagohri T; Inoue K; Ogino T; Ikeda H; Maru Y; Yoshino M
Cancer; 2003 Mar; 97(5):1346-52. PubMed ID: 12599244
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma.
Brizel DM; Murphy BA; Rosenthal DI; Pandya KJ; Glück S; Brizel HE; Meredith RF; Berger D; Chen MG; Mendenhall W
J Clin Oncol; 2008 May; 26(15):2489-96. PubMed ID: 18487568
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906).
Kato K; Muro K; Minashi K; Ohtsu A; Ishikura S; Boku N; Takiuchi H; Komatsu Y; Miyata Y; Fukuda H;
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):684-90. PubMed ID: 20932658
[TBL] [Abstract][Full Text] [Related]
16. Phase 1 trial of combined chemotherapy and reirradiation for recurrent unresectable head and neck cancer.
Spencer S; Wheeler R; Peters G; Meredith R; Beenken S; Nabel L; Wooten A; Soong SJ; Salter M
Head Neck; 2003 Feb; 25(2):118-22. PubMed ID: 12509794
[TBL] [Abstract][Full Text] [Related]
17. Phase I study of hyperfractionated radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic cancer.
Ueno H; Okusaka T; Ikeda M; Tokuuye K
Oncology; 2004; 67(3-4):215-21. PubMed ID: 15557781
[TBL] [Abstract][Full Text] [Related]
18. [The first report from Sapporo Tsukisamu Hospital--chemotherapy and chemoradiotherapy for patients with advanced pancreatic cancer].
Yamamitsu S; Kimura H; Yamada Y; Inui N; Hiyama S; Hirata K; Kimura Y; Koito K; Shirasaka T
Gan To Kagaku Ryoho; 2007 Jul; 34(7):1059-66. PubMed ID: 17637542
[TBL] [Abstract][Full Text] [Related]
19. 5-fluorouracil-based chemoradiation in unresectable pancreatic carcinoma: Phase I-II dose-escalation study.
Morganti AG; Valentini V; Macchia G; Mattiucci GC; Costamagna G; Deodato F; Smaniotto D; Luzi S; Balducci M; Barbi S; Perri V; Trodella L; Cellini N
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1454-60. PubMed ID: 15275732
[TBL] [Abstract][Full Text] [Related]
20. [Phase I study of CM-Na combined with concurrent radiochemotherapy for advanced esophageal carcinoma].
Cai L; Liu MZ; Gu MF; Liu H; Chen EC; Hu YH; Lin HX; Wang HY; Huang Y; Li QQ; Cui NJ; Rong TH
Ai Zheng; 2005 May; 24(5):582-6. PubMed ID: 15890102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
